Literature DB >> 20851775

The neuro-steroid, 5-androstene 3β,17α diol; induces endoplasmic reticulum stress and autophagy through PERK/eIF2α signaling in malignant glioma cells and transformed fibroblasts.

Wentao Jia1, Roger M Loria, Margaret A Park, Adly Yacoub, Paul Dent, Martin R Graf.   

Abstract

In this study, we identified a mechanism by which the neuro-steroid, 5-androstene 3β,17α diol (17α-AED) induces autophagy in human malignant glioma cells and transformed fibroblasts. 17α-AED treatment induced endoplasmic reticulum (ER) stress, identified by the partial activation of an unfolded protein response in T98G, U87MG, U251MG, LN-18, LN-229 and LN-Z308 glioma cell lines. In this regard, there were increased levels of CCAAT/enhancer-binding protein homologous protein (CHOP) and glucose-regulated protein of 78kDa transcripts but no splicing of X-box-binding protein 1 mRNA or processing of activating transcription factor-6 in glioma cells treated with the neuro-steroid. 17α-AED induced eukaryotic translational initiation factor 2α (eIF2α) phosphorylation in glioma cells which correlated with microtubule-associated protein-light chain 3 (LC3) conversion from LC3-I to -II. In transformed murine embryonic fibroblasts (MEFs) that are deficient of eIF2α function or T98G glioma cells transfected with a dominant-negative eIF2α construct, 17α-AED induced LC3 conversion was significantly reduced as compared to control cells. Neuro-steroid treatment caused the activation of the eIF2α kinase, protein kinase-like ER kinase (PERK) but not other eIF2α kinases in glioma cells. Moreover, eIF2α phosphorylation and LC3 conversion, in response to 17α-AED treatment, was blocked in MEFs that lacked PERK activity. T98G cells transfected with a dominant-negative PERK construct exhibited an attenuated response to neuro-steroid treatment in terms of decreases in: eIF2α activation; CHOP expression; the incidence of autophagy; and cytotoxicity. These results demonstrate that ER stress is linked to 17α-AED induced autophagy by PERK/eIF2α signaling in human malignant glioma cells and transformed fibroblasts.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851775     DOI: 10.1016/j.biocel.2010.09.003

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  7 in total

1.  Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1.

Authors:  Nichola Cruickshanks; Hossein A Hamed; M Danielle Bareford; Andrew Poklepovic; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2012-02-22       Impact factor: 4.436

2.  Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress.

Authors:  Nichola Cruickshanks; Yong Tang; Laurence Booth; Hossein Hamed; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2012-09-18       Impact factor: 4.436

3.  ER Stress and Lipid Metabolism in Adipocytes.

Authors:  Beth S Zha; Huiping Zhou
Journal:  Biochem Res Int       Date:  2012-02-12

Review 4.  Characterizing Cell Stress and GRP78 in Glioma to Enhance Tumor Treatment.

Authors:  Kristie Liu; Kathleen Tsung; Frank J Attenello
Journal:  Front Oncol       Date:  2020-12-11       Impact factor: 6.244

5.  2-Hydroxyoleic acid induces ER stress and autophagy in various human glioma cell lines.

Authors:  Amaia Marcilla-Etxenike; Maria Laura Martín; Maria Antònia Noguera-Salvà; José Manuel García-Verdugo; Mario Soriano-Navarro; Indranil Dey; Pablo V Escribá; Xavier Busquets
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

6.  Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3.

Authors:  Ronghong Li; Xiang Li; Shangwei Ning; Jingrun Ye; Lei Han; Chunsheng Kang; Xia Li
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

Review 7.  Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.

Authors:  Marina Digregorio; Arnaud Lombard; Paul Noel Lumapat; Félix Scholtes; Bernard Rogister; Natacha Coppieters
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.